CAR T-Cell Therapy Remains Underutilized, Despite Improvements in Access.

MLA

Berberabe, Tony. “CAR T-Cell Therapy Remains Underutilized, Despite Improvements in Access.” Targeted Therapies in Oncology, vol. 13, no. 9, July 2024, pp. 16–18. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=178370729&authtype=sso&custid=ns315887.

APA

Berberabe, T. (2024). CAR T-Cell Therapy Remains Underutilized, Despite Improvements in Access. Targeted Therapies in Oncology, 13(9), 16–18.

Chicago

Berberabe, Tony. 2024. “CAR T-Cell Therapy Remains Underutilized, Despite Improvements in Access.” Targeted Therapies in Oncology 13 (9): 16–18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=178370729&authtype=sso&custid=ns315887.